Revolution Medicines (RVMD) Current Leases: 2020-2025
Historic Current Leases for Revolution Medicines (RVMD) over the last 6 years, with Sep 2025 value amounting to $16.3 million.
- Revolution Medicines' Current Leases rose 94.45% to $16.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.3 million, marking a year-over-year increase of 94.45%. This contributed to the annual value of $12.9 million for FY2024, which is 74.68% up from last year.
- According to the latest figures from Q3 2025, Revolution Medicines' Current Leases is $16.3 million, which was up 24.74% from $13.1 million recorded in Q2 2025.
- In the past 5 years, Revolution Medicines' Current Leases ranged from a high of $16.3 million in Q3 2025 and a low of $3.7 million during Q1 2021.
- Moreover, its 3-year median value for Current Leases was $8.3 million (2024), whereas its average is $9.5 million.
- Per our database at Business Quant, Revolution Medicines' Current Leases decreased by 17.98% in 2023 and then surged by 94.45% in 2025.
- Quarterly analysis of 5 years shows Revolution Medicines' Current Leases stood at $6.2 million in 2021, then grew by 9.00% to $6.8 million in 2022, then climbed by 8.80% to $7.4 million in 2023, then surged by 74.68% to $12.9 million in 2024, then surged by 94.45% to $16.3 million in 2025.
- Its last three reported values are $16.3 million in Q3 2025, $13.1 million for Q2 2025, and $13.0 million during Q1 2025.